Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1987 Feb;80(2):70–73. doi: 10.1177/014107688708000204

Lymphomania. Non-Hodgkin's lymphoma as possibly viewed through the eyes of Lewis Carroll.

E Glatstein
PMCID: PMC1290672  PMID: 3560148

Full text

PDF
70

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson T., Bender R. A., Fisher R. I., DeVita V. T., Chabner B. A., Berard C. W., Norton L., Young R. C. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup. Cancer Treat Rep. 1977 Sep;61(6):1057–1066. [PubMed] [Google Scholar]
  2. Cabanillas F., Bodey G. P., Freireich E. J. Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic types. Cancer. 1980 Dec 1;46(11):2356–2359. doi: 10.1002/1097-0142(19801201)46:11<2356::aid-cncr2820461107>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  3. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  4. Coleman C. N., Williams C. J., Flint A., Glatstein E. J., Rosenberg S. A., Kaplan H. S. Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med. 1977 Dec 8;297(23):1249–1252. doi: 10.1056/NEJM197712082972303. [DOI] [PubMed] [Google Scholar]
  5. Coltman C. A., Jr, Dixon D. O. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup. Cancer Treat Rep. 1982 Apr;66(4):1023–1033. [PubMed] [Google Scholar]
  6. DeVita V. T., Jr, Canellos G. P., Chabner B., Schein P., Hubbard S. P., Young R. C. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet. 1975 Feb 1;1(7901):248–250. doi: 10.1016/s0140-6736(75)91142-3. [DOI] [PubMed] [Google Scholar]
  7. Fuks Z., Glatstein E., Kaplan H. S. Patterns of presentation and relapse in the non-Hodgkin's lymphomata. Br J Cancer Suppl. 1975 Mar;2:286–297. [PMC free article] [PubMed] [Google Scholar]
  8. Greene M. H., Young R. C., Merrill J. M., DeVita V. T. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Res. 1983 Apr;43(4):1891–1898. [PubMed] [Google Scholar]
  9. Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Mar 4;306(9):517–522. doi: 10.1056/NEJM198203043060906. [DOI] [PubMed] [Google Scholar]
  10. Portlock C. S., Rosenberg S. A. No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med. 1979 Jan;90(1):10–13. doi: 10.7326/0003-4819-90-1-10. [DOI] [PubMed] [Google Scholar]
  11. Rosenberg S. A. Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities. J Clin Oncol. 1985 Mar;3(3):299–310. doi: 10.1200/JCO.1985.3.3.299. [DOI] [PubMed] [Google Scholar]
  12. Tester W. J., Kinsella T. J., Waller B., Makuch R. W., Kelley P. A., Glatstein E., DeVita V. T. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol. 1984 Jul;2(7):762–769. doi: 10.1200/JCO.1984.2.7.762. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES